Steven Corso

859 total citations
9 papers, 421 citations indexed

About

Steven Corso is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Steven Corso has authored 9 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Steven Corso's work include Estrogen and related hormone effects (3 papers), Cancer survivorship and care (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). Steven Corso is often cited by papers focused on Estrogen and related hormone effects (3 papers), Cancer survivorship and care (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). Steven Corso collaborates with scholars based in United States, India and United Kingdom. Steven Corso's co-authors include John D. Hainsworth, Lisa H. Morrissey, Howard A. Burris, F. Anthony Greco, Denise A. Yardley, Daniel C. Scullin, Sharlene Litchy, John W. Kugler, Amylou C. Dueck and Ernie Balcueva and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Steven Corso

8 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Corso United States 4 288 216 165 88 66 9 421
L Pan United Kingdom 6 246 0.9× 149 0.7× 79 0.5× 22 0.3× 82 1.2× 8 371
Nilima Parry‐Jones United Kingdom 13 318 1.1× 169 0.8× 319 1.9× 19 0.2× 100 1.5× 21 500
G Stein United States 6 420 1.5× 297 1.4× 203 1.2× 63 0.7× 54 0.8× 8 521
Sabine Oeschger Germany 8 140 0.5× 68 0.3× 65 0.4× 15 0.2× 45 0.7× 9 243
Gianluigi Reda Italy 11 156 0.5× 70 0.3× 302 1.8× 18 0.2× 136 2.1× 57 457
Pär Josefsson Denmark 10 252 0.9× 124 0.6× 179 1.1× 38 0.4× 109 1.7× 18 369
Gerasimos Pangalis Greece 9 184 0.6× 71 0.3× 233 1.4× 13 0.1× 75 1.1× 21 376
Max J. Gordon United States 11 209 0.7× 120 0.6× 169 1.0× 6 0.1× 51 0.8× 44 359
Christos Karkantaris Greece 7 225 0.8× 166 0.8× 194 1.2× 39 0.4× 63 1.0× 9 402
George Kanellis Greece 7 123 0.4× 69 0.3× 83 0.5× 9 0.1× 43 0.7× 18 214

Countries citing papers authored by Steven Corso

Since Specialization
Citations

This map shows the geographic impact of Steven Corso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Corso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Corso more than expected).

Fields of papers citing papers by Steven Corso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Corso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Corso. The network helps show where Steven Corso may publish in the future.

Co-authorship network of co-authors of Steven Corso

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Corso. A scholar is included among the top collaborators of Steven Corso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Corso. Steven Corso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Belcher, Elizabeth, Eva Culakova, Nikesha Gilmore, et al.. (2022). Inflammation, Attention, and Processing Speed in Patients With Breast Cancer Before and After Chemotherapy. JNCI Journal of the National Cancer Institute. 114(5). 712–721. 13 indexed citations
3.
Gilmore, Nikesha, Elizabeth Belcher, Po‐Ju Lin, et al.. (2021). Association of changes of pro-inflammatory markers with physical function in women with breast cancer receiving chemotherapy.. Journal of Clinical Oncology. 39(15_suppl). 562–562. 1 indexed citations
4.
Tripathy, Debu, Joanne L. Blum, Gabrielle B. Rocque, et al.. (2021). Abstract SS2-10: Impact of COVID-19 on study sites: Survey analysis from the noninterventional POLARIS study. Cancer Research. 81(4_Supplement). SS2–10. 1 indexed citations
5.
Hertz, Daniel L., Anna C. Snavely, Howard L. McLeod, et al.. (2015). Abstract P1-03-02: CYP2D6 intermediate metabolizers includes patient groups with distinct metabolic activity. Cancer Research. 75(9_Supplement). P1–3. 1 indexed citations
6.
Hertz, Daniel L., Anna C. Snavely, James P. Evans, et al.. (2014). Does increasing the daily tamoxifen dose in patients with diminished CYP2D6 activity increase toxicity?. Journal of Clinical Oncology. 32(15_suppl). 561–561. 3 indexed citations
7.
Loprinzi, Charles L., John W. Kugler, Debra L. Barton, et al.. (2006). Phase III Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone: NCCTG N03C5. Journal of Clinical Oncology. 25(3). 308–312. 69 indexed citations
8.
Greco, F. Anthony, Dana S. Thompson, Lisa H. Morrissey, et al.. (2005). Paclitaxel/Carboplatin/Etoposide Versus Paclitaxel/Topotecan for Extensive-Stage Small Cell Lung Cancer: A Minnie Pearl Cancer Research Network Randomized, Prospective Phase II Trial. The Oncologist. 10(9). 728–733. 12 indexed citations
9.
Hainsworth, John D., Sharlene Litchy, Howard A. Burris, et al.. (2002). Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s Lymphoma. Journal of Clinical Oncology. 20(20). 4261–4267. 321 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026